PAA 0.00% 20.0¢ pharmaust limited

It is an old chestnut regarding patents. i understand newer...

  1. 276 Posts.
    lightbulb Created with Sketch. 368
    It is an old chestnut regarding patents. i understand newer investors may have a concern.

    The composition of matter patent has been held by Elanco, but is due to expire in most jurisdictions this year.

    PAA hold multiple patents for the use of monepantel for numerous indications through their subsidiary company Pitney Pharmaceuticals.
    These include neuro-degenerative diseases, human cancers, anti-virals and canine lymphomas. All our patents have a long runway.

    There are no impediments to PAA pursuing it's clinical program and negotiation of commercial deals.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.000(0.00%)
Mkt cap ! $97.22M
Open High Low Value Volume
20.0¢ 20.0¢ 19.5¢ $244.3K 1.244M

Buyers (Bids)

No. Vol. Price($)
1 100000 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 257206 7
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.